-
Senate Democrats spent the weekend advancing what they call a historic piece of legislation, but it's still a much smaller version of what they — and President Biden — originally called for.
-
The Arizona senator said she will move forward with the Inflation Reduction Act after Democrats reached an agreement to remove a carried interest tax provision.
-
Two Washington Post journalists say pharmaceutical companies collaborated with each other — and with lawyers and lobbyists — to create laws to protect the industry. Their new book is American Cartel.
-
Even the savviest Medicare drug plan shoppers can get a shock when they fill prescriptions: That great deal on medications in fall is no bargain after prices go up as much as 8% by winter.
-
Oklahoma was one of the first states to successfully sue drugmakers for their role in the opioid epidemic, but almost none of that money has been spent so far. A bill moving through the legislature could change that.
-
The Sacklers, who own Purdue Pharma, maker of Oxycontin, have maintained they did nothing wrong. People who lost loved ones and years of their lives to opioid addiction believe otherwise.
-
The deal, hashed out over weeks of intense negotiations, raises the amount paid by the Sacklers by more than $1 billion. In exchange, the family members win immunity from civil opioid lawsuits.
-
Companies at the center of the deadly prescription opioid epidemic are close to deals that would cap their liability while funding drug treatment and recovery programs.
-
The lawsuit brought by more than 100 tribal nations will benefit all 574 federally recognized tribes.
-
Johnson & Johnson, AmerisourceBergen, McKesson and Cardinal Health will pay $590 million to Native American tribes under a proposed settlement for the companies' role in the opioid crisis.